These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16682809)

  • 21. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting.
    Bogoyevitch MA
    Bioessays; 2006 Sep; 28(9):923-34. PubMed ID: 16937364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.
    Mehan S; Meena H; Sharma D; Sankhla R
    J Mol Neurosci; 2011 Mar; 43(3):376-90. PubMed ID: 20878262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Caron M; Atfi A; Cherqui G; Capeau J
    Endocrinology; 2000 Mar; 141(3):922-31. PubMed ID: 10698166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JNK signaling as a target for anticancer therapy.
    Abdelrahman KS; Hassan HA; Abdel-Aziz SA; Marzouk AA; Narumi A; Konno H; Abdel-Aziz M
    Pharmacol Rep; 2021 Apr; 73(2):405-434. PubMed ID: 33710509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of SAPK/JNKs in vitro.
    Chadee DN; Kyriakis JM
    Methods Mol Biol; 2010; 661():59-73. PubMed ID: 20811976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The JNK signal transduction pathway.
    Weston CR; Davis RJ
    Curr Opin Cell Biol; 2007 Apr; 19(2):142-9. PubMed ID: 17303404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway.
    Coso OA; Chiariello M; Kalinec G; Kyriakis JM; Woodgett J; Gutkind JS
    J Biol Chem; 1995 Mar; 270(10):5620-4. PubMed ID: 7890682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis.
    Oktay K; Buyuk E; Oktem O; Oktay M; Giancotti FG
    Cell Cycle; 2008 Feb; 7(4):533-41. PubMed ID: 18431843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between non-coding RNAs and JNK in human disorders.
    Ghafouri-Fard S; Abak A; Mohaqiq M; Shoorei H; Taheri M
    Biomed Pharmacother; 2021 Jun; 138():111497. PubMed ID: 33735819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of JNK in tumor development.
    Kennedy NJ; Davis RJ
    Cell Cycle; 2003; 2(3):199-201. PubMed ID: 12734425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JNK Signaling as a Key Modulator of Soft Connective Tissue Physiology, Pathology, and Healing.
    Nikoloudaki G; Brooks S; Peidl AP; Tinney D; Hamilton DW
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins.
    Waetzig V; Herdegen T
    Mol Cell Neurosci; 2003 Sep; 24(1):238-49. PubMed ID: 14550783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RACK1 mediates activation of JNK by protein kinase C [corrected].
    López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
    Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells.
    Helbig L; Damrot J; Hülsenbeck J; Köberle B; Brozovic A; Osmak M; Fiket Z; Kaina B; Fritz G
    J Biol Chem; 2011 Apr; 286(15):12991-3001. PubMed ID: 21324906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of JNK signaling in oral cancer: A mini review.
    Gkouveris I; Nikitakis NG
    Tumour Biol; 2017 Jun; 39(6):1010428317711659. PubMed ID: 28639904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes.
    Bogoyevitch MA; Ketterman AJ; Sugden PH
    J Biol Chem; 1995 Dec; 270(50):29710-7. PubMed ID: 8530360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The functional contrariety of JNK.
    Bode AM; Dong Z
    Mol Carcinog; 2007 Aug; 46(8):591-8. PubMed ID: 17538955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.